Gastric Antral Injections of Botulinum Toxin Delay Gastric Emptying but Do Not Reduce Body Weight

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 2, 2013, Pages

  Topazian, Mark ^a   Camilleri, Michael ^a   Enders, Felicity T ^a   Clain, Jonathan E ^a   Gleeson, Ferga C ^a   Levy, Michael J ^a   Rajan, Elizabeth ^a   Nehra, Vandana ^a   Dierkhising, Ross A ^a   Collazo Clavell, Maria L ^a   Talley, Nicholas J ^a   Clark, Matthew M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Endoscopy; ; Motility.; Obesity; ; Therapy;

Indexed keywords

ANTIOBESITY AGENT; BOTULINUM TOXIN A; PLACEBO; SODIUM CHLORIDE;

ADULT; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEEDING BEHAVIOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; RANDOMIZED CONTROLLED TRIAL; SATIETY; STOMACH EMPTYING; STOMACH SCINTISCANNING; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 84872373873     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.09.029     Document Type: Article

References (28)

1. Albani G., Petroni M., Mauro A., et al. Safety and efficacy of therapy with botulinum toxin in obesity: a pilot study. J Gastroenterol 2005, 40:833-835.
2. Cardoso Junior A.C., Savassi-Rocha P.R., Vaz Coelho L.G., et al. Botulinum A toxin injected into the gastric wall for the treatment of class III obesity: a pilot study. Obes Surg 2006, 16:335-343.
3. Coskun H., Duran Y., Dilege E., et al. Effect on gastric emptying and weight reduction of botulinum toxin-A injection into the gastric antral layer: an experimental study in the obese rat model. Obes Surg 2005, 15:1137-1143.
4. Foschi D., Corsi F., Lazzaroni M., et al. Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study. Int J Obes 2007, 31:707-712.
5. García-Compean D., Mendoza-Fuerte E., Martínez J., et al. Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity: results of a pilot study. Gastroenterol Clin Biol 2005, 29:789-791.
6. Gui D., De Gaetano A., Spada P.L., et al. Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats. Aliment Pharmacol Ther 2000, 14:829-834.
7. Gui D., Mingrone G., Valenza V., et al. Effect of botulinum toxin antral injection on gastric emptying and weight reduction in obese patients: a pilot study. Aliment Pharmacol Ther 2006, 23:675-680.
8. Mittermair R., Keller C., Geibel J. Intragastric injection of botulinum toxin A for the treatment of obesity. Obes Surg 2007, 17:732-736.
9. Rollnik J.D., Manns M.P., Goke M., et al. Antral injections of botulinum A toxin for the treatment of obesity. Ann Intern Med 2003, 138:359-360.
10. Topazian M., Camilleri M., De La Mora-Levy J., et al. Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study. Obes Surg 2008, 18:401-407.
11. Li L., Liu Q.S., Liu W.H., et al. Treatment of obesity by endoscopic gastric intramural injection of botulinum toxin A: a randomized clinical trial. Hepatogastroenterology 2012, 59:2003-2007.
12. Talley N., Phillips S., Melton J., et al. A patient questionnaire to identify bowel disease. Ann Intern Med 1989, 111:671-674.
13. Cremonini F., Mullan B., Camilleri M., et al. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther 2002, 16:1781-1790.
14. Abbruzzese G., Berardelli A. Neurophysiological effects of botulinum toxin type A. Neurotox Res 2006, 9:109-114.
15. Tack J., Coulie B., Caenepeel P., et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998, 115:1346-1352.
16. Delgado-Aros S., Cremonini F., Castillo J., et al. Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology 2004, 126:432-440.
17. Dimenäs E., Glise H., Hallerbäck B., et al. Quality of life in patients with upper gastrointestinal symptoms: an improved evaluation of treatment regimens?. Scand J Gastroenterol 1993, 28:681-687.
18. Talley N., Fullerton S., Junghard O., et al. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol 2001, 96:1998-2004.
19. Patterson R., Kristal A., Tinker L., et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 1999, 9:178-187.
20. Yanovski S. Binge eating disorder: current knowledge and future directions. Obes Res 1993, 1:306-324.
21. Clark M., Abrams D., Niaura R., et al. Self-efficacy in weight management. J Consult Clin Psychol 1991, 59:739-744.
22. Stunkard A., Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985, 29:71-83.
23. Diggle P., Liang K., Zeger S. Analysis of longitudinal data 1994, Clarendon Press, Wotton-Under-Edge, United Kingdom.
24. Camilleri M., Iturrino J., Bharucha A.E., et al. Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants. Neurogastroenterol Motil 2012 Jul 2, Epub ahead of print.
25. Camilleri M., Malagelada J.R., Brown M.L., et al. Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol 1985, 249:G580-G585.
26. Camilleri M., Brown M.L., Malagelada J.R. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology 1986, 91:94-99.
27. James A., Ryan J., Parkman H. Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle. Am J Physiol Gastrointest Liver Physiol 2003, 285:G291-G297.
28. Cremonini F., Camilleri M., Clark M.M., et al. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes 2009, 33:342-353.